Michael Ullmann

Active Investor

Adjunct Faculty Member at Columbia University

Princeton, New Jersey

Michael Ullmann, Adjunct Faculty Member at Columbia University is an active investor based in Princeton, New Jersey. This profile covers what Michael Ullmann backs, at which stage, and how founders can reach out in 2026.

Mr. Michael Ullmann serves as Vice President & General Counsel at Johnson & Johnson. Mr. Ullmann joined Johnson & Johnson as a mergers and acquisitions attorney in 1989. He also served on the Management Boards of Johnson & Johnson Consumer Products Company, Inc., Janssen Pharmaceuticals, Inc. (U.S.), McNeil Pharmaceuticals, and Johnson & Johnson Sales and Logistics Company, LLC. Mr. Ullmann served as Corporate Secretary from 1999 to 2006. During that time, he also held various management positions in the Law Department. In 2002, Mr. Ullmann was appointed as a member of the Law Department Operating Committee and Associate General Counsel. In 2006, Mr. Ullmann was appointed General Counsel of the Medical Devices and Diagnostics Group. He assumed his current responsibilities in January 2012. Before joining Johnson & Johnson, Mr. Ullmann practiced law in New York City. He graduated magna cum laude from Cornell University, College of Arts & Sciences, and earned his law degree from Columbia University School of Law.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechBiotech & PharmaIoT & Connected DevicesMobility & LogisticsSupply Chain & LogisticsPropTech & Real EstateEdTech
Location: Princeton, New Jersey
Typical check: $500K
Past investments: 5

Notable investments

Naples Zoo (non-profit)AmericaresCytogel Pharma, LLCSalaryoPrinceton Area Community Foundation

How to reach Michael Ullmann

Angels and operators like Michael Ullmann reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Michael Ullmann invest in?

Michael Ullmann invests in Healthcare & Biotech, Biotech & Pharma, IoT & Connected Devices and Mobility & Logistics, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.